Durbin AP - Search Results

1

Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model.

Santiago HC, Pereira-Neto TA, Gonçalves-Pereira MH, Terzian ACB, Durbin AP. Santiago HC, et al. Among authors: durbin ap. Pathogens. 2022 Feb 25;11(3):294. doi: 10.3390/pathogens11030294. Pathogens. 2022. PMID: 35335618 Free PMC article. Review.

2

Zika Vaccines: Role for Controlled Human Infection.

Durbin AP, Whitehead SS. Durbin AP, et al. J Infect Dis. 2017 Dec 16;216(suppl_10):S971-S975. doi: 10.1093/infdis/jix491. J Infect Dis. 2017. PMID: 29267920 Free PMC article. Review.

3

Dengue vaccine candidates in development.

Durbin AP, Whitehead SS. Durbin AP, et al. Curr Top Microbiol Immunol. 2010;338:129-43. doi: 10.1007/978-3-642-02215-9_10. Curr Top Microbiol Immunol. 2010. PMID: 19802583 Review.

4

The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.

VanBlargan LA, Mukherjee S, Dowd KA, Durbin AP, Whitehead SS, Pierson TC. VanBlargan LA, et al. Among authors: durbin ap. PLoS Pathog. 2013;9(12):e1003761. doi: 10.1371/journal.ppat.1003761. Epub 2013 Dec 5. PLoS Pathog. 2013. PMID: 24348242 Free PMC article.

5

Dengue human infection models to advance dengue vaccine development.

Larsen CP, Whitehead SS, Durbin AP. Larsen CP, et al. Among authors: durbin ap. Vaccine. 2015 Dec 10;33(50):7075-82. doi: 10.1016/j.vaccine.2015.09.052. Epub 2015 Sep 28. Vaccine. 2015. PMID: 26424605 Free article.

6

Status of vaccine research and development of vaccines for dengue.

Vannice KS, Durbin A, Hombach J. Vannice KS, et al. Vaccine. 2016 Jun 3;34(26):2934-2938. doi: 10.1016/j.vaccine.2015.12.073. Epub 2016 Mar 11. Vaccine. 2016. PMID: 26973072 Free article. Review.

7

The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model.

Kirkpatrick BD, Whitehead SS, Pierce KK, Tibery CM, Grier PL, Hynes NA, Larsson CJ, Sabundayo BP, Talaat KR, Janiak A, Carmolli MP, Luke CJ, Diehl SA, Durbin AP. Kirkpatrick BD, et al. Among authors: durbin ap. Sci Transl Med. 2016 Mar 16;8(330):330ra36. doi: 10.1126/scitranslmed.aaf1517. Epub 2016 Mar 16. Sci Transl Med. 2016. PMID: 27089205 Clinical Trial.

8

A Dengue Vaccine.

Durbin AP. Durbin AP. Cell. 2016 Jun 30;166(1):1. doi: 10.1016/j.cell.2016.06.036. Cell. 2016. PMID: 27368091 Free article.

9

Dengue Antibody and Zika: Friend or Foe?

Durbin AP. Durbin AP. Trends Immunol. 2016 Oct;37(10):635-636. doi: 10.1016/j.it.2016.08.006. Epub 2016 Sep 3. Trends Immunol. 2016. PMID: 27599407

10

Vaccine Development for Zika Virus-Timelines and Strategies.

Durbin AP. Durbin AP. Semin Reprod Med. 2016 Sep;34(5):299-304. doi: 10.1055/s-0036-1592070. Epub 2016 Sep 8. Semin Reprod Med. 2016. PMID: 27607566 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page